Who owns Acorda Therapeutics?

Key details on Acorda Therapeutics (Ticker: ACOR)

Who owns Acorda Therapeutics?

Is ACOR a good stock to own? Find out who bought Acorda Therapeutics, who sold Acorda Therapeutics (ACOR) stock, and who holds a large position in Acorda Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 6.47M $276.93M Dec. 31, 2015
Baker Bros. Advisors 3.58M $153.16M Dec. 31, 2015
Vanguard 3.28M $140.58M Dec. 31, 2015
BlackRock Fund Advisors 3.19M $136.48M Dec. 31, 2015
Adage Capital Partners GP 2.78M $118.80M Dec. 31, 2015
UBS GLOBAL ASSET MANAGEMENT AMERICAS 2.00M $52.90M Sept. 30, 2015
Scopia Management 1.95M $83.57M Dec. 31, 2015
Oracle Investment Management 1.85M $62.71M Sept. 30, 2014
Ulys 1.80M $42.91M Dec. 31, 2011
Wellington Management Company 1.76M $75.21M Dec. 31, 2015
Invus Public Equities Advisors 1.70M $54.93M June 30, 2011
Damian Sousa 1.67M $44.05M March 31, 2016
Thrivent Financial for Lutherans 1.66M $71.11M Dec. 31, 2015
STATE STREET CORPORATION 1.54M $40.94M Sept. 30, 2015
BlackRock Institutional Trust Company, N.A. 1.51M $43.95M Dec. 31, 2013
Artal Group S.A. 1.50M $49.48M June 30, 2013
Bridger Management 1.50M $39.83M March 31, 2012
GOLDMAN SACHS 1.49M $43.60M Dec. 31, 2013
Inves 1.49M $43.53M Dec. 31, 2013

Who sold Acorda Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
S.A.C. Capital Advisors June 30, 2011 2.36M $76.31M
Brookside Capital Management, LLC* June 30, 2011 1.39M $44.78M
Wells Fargo & Company March 31, 2011 2.34M $53.62M
Westfield Capital Management Company Dec. 31, 2010 1.77M $48.24M
Columbia Wanger Asset Management Sept. 30, 2010 2.06M $68.09M